Hinge Health Form 144 cites 106,729 Series B shares

Hinge Health, Inc. submitted a Form 144 notice concerning certain securities.

Rhea-AI Filing Summary

Hinge Health, Inc. submitted a Form 144 notice concerning certain securities. The filing references 106,729 units tied to Series B Preferred Stock dated 07/03/2018 and lists 06/16/2026 alongside two numeric entries: 51,637,302.00 and 54,655,926. The excerpt also names Raymond James & Associates and includes the phrase Stock Conversion before IPO.

Insights

Securities Compliance Analyst

Form 144 notice filed referencing Series B preferred and conversion details.

The excerpt lists 106,729 units associated with Series B Preferred Stock dated 07/03/2018 and notes Stock Conversion before IPO. These items describe the instrument and a conversion event.

Cash‑flow treatment and whether sales were completed are not shown in the excerpt; subsequent public filings would indicate consummation or transfer status.

Key Figures

Form reference date: 06/16/2026 Series B Preferred units: 106,729 Numeric entries listed: 51,637,302.00 and 54,655,926 +1 more

4 metrics

Form reference date 06/16/2026 date shown alongside securities line

Series B Preferred units 106,729 Series B Preferred Stock entry dated 07/03/2018

Numeric entries listed 51,637,302.00 and 54,655,926 two numeric values shown in the excerpt (labels not specified)

Series B instrument date 07/03/2018 date attached to Series B Preferred Stock line

Key Terms

Stock Conversion before IPO, Series B Preferred Stock, Wired to portfolio company

3 terms

Stock Conversion before IPO financial

"Stock Conversion before IPO"

Series B Preferred Stock financial

"Series B Preferred Stock | 07/03/2018"

Series B preferred stock is a type of ownership share issued by a company that offers certain advantages over common stock, such as priority in receiving dividends or assets if the company is sold or liquidated. It is typically issued after an initial round of funding, making it a way for investors to support a company's growth while gaining some protections and benefits. This stock matters to investors because it often provides a more secure investment position with potential for future growth.

Wired to portfolio company operational

"Wired to portfolio company"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does HNGE's Form 144 reference?

It references 106,729 units associated with Series B Preferred Stock dated 07/03/2018. The excerpt also includes terms such as Stock Conversion before IPO and lists numeric entries 51,637,302.00 and 54,655,926.

Does the excerpt show who the broker is for the transaction?

Yes. The filing text names Raymond James & Associates with an address in St. Petersburg, FL. No further broker instructions or transaction status appear in the provided excerpt.

Is there a filing date shown for the Form 144 content?

The excerpt includes the date 06/16/2026 in the securities line. The text also shows the instrument date 07/03/2018 tied to the Series B Preferred Stock entry.

Does the excerpt state whether proceeds or sales were completed?

No. The provided excerpt contains phrases like Wired to portfolio company and instrument details, but it does not state completion, proceeds, or whether securities were sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/16/2026 - 05:38 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001710959
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 MARKET STREET 7TH FLOOR SAN FRANCISCO CALIFORNIA 94105
Phone	415-689-8429
Name of Person for Whose Account the Securities are To Be Sold	Insight Venture Partners X, L.P.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Class A	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	732444	51637302.00	54655926	06/16/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Series B Preferred Stock	07/03/2018	Stock Conversion before IPO	Hinge Health, Inc.			106729	07/03/2018	Wired to portfolio company

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	06/16/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rashida Mitchell, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Jonathan Grossman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)